Trials / Completed
CompletedNCT06043882
Number of Participants Diagnosed With Sarcoidosis by Bronchoscopic Transbronchial Needle Aspiration After COVID- 2019 .
Number of Participants Diagnosed With Sarcoidosis by Bronchoscopic Transbronchial Needle Aspiration After Corona Virus Disease of 2019 Infection.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 55 (actual)
- Sponsor
- Ain Shams University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this observational study is to learn about sarcoidosis development after COVID-19 infection. The main question it aims to answer is: * prevalence of Sarcoidosis among patients previously infected with COVID-19. Participants will: * provide previous positive RT-PCR for COVID-19 * Have computed tomography of the Chest with suggestive findings of sarcoidosis * Have bronchoscopic guided biopsies and pathological analysis to detect number of patients with sarcoidosis.
Detailed description
This prospective cross sectional study was performed on a total of 55 patients with mediastinal and /or hilar lymphadenopathy with or without lung infiltrates referred to Bronchoscopy unit , Chest department, Ain-Shams University hospital for biopsy taking and diagnosis. All patients were subjected to the following : history taking , clinical examination , radiological assessment by computed tomography (CT )chest , fiberoptic bronchoscopy where biopsies were taken either by conventional-Trans-bronchial needle aspiration (c-TBNA) , endo-bronchial ultrasound (EBUS-TBNA) or direct forceps biopsies and sent for histopathological examination and if the patient had past history of COVID-19 infection with previous positive reverse transcriptase- polymerase chain reaction assay (RT-PCR).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | flexible bronchoscopy | fiberoptic bronchoscopy was done where biopsies were taken either by conventional TBNA (c-TBNA) , EBUS-TBNA or direct forceps biopsies and sent for histopathological examination |
Timeline
- Start date
- 2022-11-01
- Primary completion
- 2023-04-30
- Completion
- 2023-05-30
- First posted
- 2023-09-21
- Last updated
- 2023-09-22
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06043882. Inclusion in this directory is not an endorsement.